Novo Nordisk

Thumbnail for Novo Nordisk advances Wegovy label, expands genetic medicine portfolio with NanoVation partnership

20 September 2024

Novo Nordisk advances Wegovy label, expands genetic medicine portfolio with NanoVation partnership

Thumbnail for UK approves Novo Nordisk’s Wegovy for cardiovascular event prevention in obese adults

24 July 2024

UK approves Novo Nordisk’s Wegovy for cardiovascular event prevention in obese adults

Thumbnail for Novo Nordisk’s weekly insulin for type 1 diabetes faces FDA setback

11 July 2024

Novo Nordisk’s weekly insulin for type 1 diabetes faces FDA setback

Thumbnail for Novo Nordisk takes US$816M hit as ocedurenone trial flops

28 June 2024

Novo Nordisk takes US$816M hit as ocedurenone trial flops

Thumbnail for South Africa faces insulin pen shortage as pharma prioritizes weight-loss drugs

27 June 2024

South Africa faces insulin pen shortage as pharma prioritizes weight-loss drugs

Thumbnail for Novo Nordisk invests US$4.1B for new manufacturing plant in North Carolina

26 June 2024

Novo Nordisk invests US$4.1B for new manufacturing plant in North Carolina

Thumbnail for Weight-Loss drug demand to propels sales to US$150B by 2030s

30 May 2024

Weight-Loss drug demand to propels sales to US$150B by 2030s

Thumbnail for FDA concerned about Novo Nordisk’s weekly Insulin

23 May 2024

FDA concerned about Novo Nordisk’s weekly Insulin

Thumbnail for Novo Nordisk records US$ 1.5 billion sales in Q1 2024, fueled by obesity drug

7 May 2024

Novo Nordisk records US$ 1.5 billion sales in Q1 2024, fueled by obesity drug

Thumbnail for Novo Nordisk acquires Cardior Pharmaceuticals for US$1.11B to strengthen heart disease portfolio

26 March 2024

Novo Nordisk acquires Cardior Pharmaceuticals for US$1.11B to strengthen heart disease portfolio